XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities    
Net loss $ (15,966) $ (14,851)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of right-of-use assets 268 23
Depreciation 57
Change in fair value of short-term investment 12 1,517
Change in fair value of long-term investment 482 (1,608)
Research and development-acquired license, expensed   525
Stock-based compensation 1,485 1,475
Realized loss on marketable securities 1,249 712
Unrealized (gain) loss on marketable securities (897) 3,889
Unrealized loss on note receivable 212
Changes in operating assets and liabilities:    
Prepaid expenses and other assets (229) (344)
Prepaid acquisition cost 301
Clearing broker deposits (3,622)
Accounts payable and accrued expenses (345) 137
Accrued salaries and benefits (628) 659
Accrued commissions 152
Lease liabilities 11 12
Other current liabilities 66
Notes receivable, at fair value – net interest accrued (96) (521)
Deposit (295)
Net cash used in operating activities (17,488) (8,670)
Cash flows from investing activities    
Purchase of marketable securities (34,068) (27,479)
Sale of marketable securities 24,572 28,503
Proceeds from sale of digital currencies 93
Purchase of fixed assets (419)
Acquisition of FPS, net of cash acquired and receivable owed from FPS (1,112)
Collection of principal on note receivable 850
Funds to employee forgivable loan (107)
Purchase of research and development licenses   (525)
Purchase of short-term and long-term investments (75) (15,016)
Purchase of short-term and long-term promissory notes (1,600)
Net cash used in investing activities (10,359) (16,024)
Cash flows from financing activities    
Proceeds from issuance of Series O and Series P Redeemable Convertible Preferred Stock, net of discount and offering cost 17,891
Payment for fractional shares (26)
Redemption of Series O and Series P Redeemable Convertible Preferred Stock (22,000)
Purchase of treasury stock (939) (2,237)
Net cash used in financing activities (939) (6,372)
Net decrease in cash and cash equivalents and restricted cash (28,786) (31,066)
Cash and cash equivalents, beginning of period 33,174 65,562
Cash and cash equivalents, end of period 4,388 34,496
Non-cash investing and financing activities    
Transfer from short-term investment to marketable securities 1,497
Reclassify from convertible note receivable to notes receivable at fair value 2,147
Promissory convertible note receivable conversion into common shares $ 899
On March 27, 2023, the Company acquired all assets and liabilities of FPS as disclosed in Note 4:    
Net assets acquired, net of cash acquired and receivable owed from FPS 3,112  
Less - Deposit previously transferred in October 2022 to FPS (2,000)  
Net cash paid $ 1,112